Saturday, October 1, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

SAN JOSE, Calif. - Vivus goosed its stock price by misrepresenting the prospects of its proposed obesity drug, Qnexa, shareholders claim in a federal class action.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.